Follow the people · Insider
Aaron Rosenberg
Aaron Rosenberg files insider transactions with the SEC as a chief financial officer of BeOne Medicines (ONC). We hold 2 disclosed purchases and sales filed since 13 August 2024, 2 of them in the last 90 days.
- Files forONC
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure5 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 10 June 2025 — 3 August 2026Chief Financial Officer · BeOne Medicines (ONC)11 Form 4 lines · source: SEC Form 4
- Filed 9 August 2024 — 5 March 2025Chief Financial Officer · BeiGene (BGNE)3 Form 4 lines · source: SEC Form 4
Everything they disclosed
14 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 1,157 shares of BeOne MedicinesSEC Form 45 August 2026American Depositary Shares · traded 3 August 2026 · filed 5 August 2026
- was granted 71,175 shares of BeOne MedicinesSEC Form 415 June 2026Ordinary Shares · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 631 shares of BeOne MedicinesSEC Form 415 June 2026American Depositary Shares · traded 11 June 2026 · filed 15 June 2026
- was granted 137,865 shares of BeOne Medicines (a derivative holding)SEC Form 415 June 2026Share Option (Right to Buy) · traded 11 June 2026 · filed 15 June 2026
- was granted 79,014 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 40,573 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 79,014 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- was granted 40,573 shares of BeOne MedicinesSEC Form 410 March 2026Ordinary Shares · traded 6 March 2026 · filed 10 March 2026
- ▼ sold on the open market 1,190 shares of BeOne MedicinesSEC Form 45 August 2025American Depositary Shares · traded 1 August 2025 · filed 5 August 2025
- was granted 119,873 shares of BeOne Medicines (a derivative holding)SEC Form 412 June 2025Share Option (Right to Buy) · traded 10 June 2025 · filed 12 June 2025
- was granted 63,674 shares of BeOne MedicinesSEC Form 412 June 2025Ordinary Shares · traded 10 June 2025 · filed 12 June 2025
- was granted 48,581 shares of BeiGeneSEC Form 47 March 2025Ordinary Shares · traded 5 March 2025 · filed 7 March 2025
- was granted 220,987 shares of BeiGene (a derivative holding)SEC Form 413 August 2024Share Option (Right to Buy) · traded 9 August 2024 · filed 13 August 2024
- was granted 118,547 shares of BeiGeneSEC Form 413 August 2024Ordinary Shares · traded 9 August 2024 · filed 13 August 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.